BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21434595)

  • 1. Leprosy beyond MDT: study of follow-up of 100 released from treatment cases.
    Vara N; Agrawal M; Marfatia Y
    Indian J Lepr; 2010; 82(4):189-94. PubMed ID: 21434595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up.
    Rao PN; Suneetha S; Pratap DV
    Lepr Rev; 2011 Sep; 82(3):244-52. PubMed ID: 22125932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term follow-up results of 1 year MDT in MB leprosy patients treated with standard MDT + once a month Minocycline and Ofloxacin.
    Katoch K; Katoch VM; Natarajan M; Gupta UD; Sharma VD; Singh HB
    Indian J Lepr; 2008; 80(4):331-44. PubMed ID: 20329382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy.
    Chen XS; Li WZ; Jiang C; Ye GY
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):379-87. PubMed ID: 10700911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on trend of relapse in leprosy and factors influencing relapse.
    Ali MK; Thorat DM; Subramanian M; Parthasarathy G; Selvaraj U; Prabhakar V
    Indian J Lepr; 2005; 77(2):105-15. PubMed ID: 16044808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand; a prospective study, 1984-1996.
    Dasananjali K; Schreuder PA; Pirayavaraporn C
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):28-36. PubMed ID: 9207751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study on the impact of FD-MDT on 200 leprosy patients.
    Vara N; Marfatiya Y
    Indian J Lepr; 2005; 77(3):217-27. PubMed ID: 16353520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapses in multibacillary leprosy patients: a retrospective cohort of 11 years in Colombia.
    Guerrero-Guerrero MI; Muvdi-Arenas S; León-Franco CI
    Lepr Rev; 2012 Sep; 83(3):247-60. PubMed ID: 23356026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy.
    Balagon MF; Cellona RV; Abalos RM; Gelber RH; Saunderson PR
    Lepr Rev; 2010 Mar; 81(1):27-33. PubMed ID: 20496567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Description of leprosy classification at baseline among patients enrolled at the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
    Moura RS; Penna GO; Cardoso LP; de Andrade Pontes MA; Cruz R; de Sá Gonçalves H; Fernandes Penna ML; de Araújo Stefani MM; Bührer-Sékula S
    Am J Trop Med Hyg; 2015 Jun; 92(6):1280-4. PubMed ID: 25940192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of relapse in leprosy after fixed-duration multidrug therapy.
    Li HY; Hu LF; Huang WB; Liu GC; Yuan LC; Jin Z; Li X; Li JL; Yang ZM
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):238-45. PubMed ID: 9251597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
    Kumar A; Girdhar A; Girdhar BK
    Indian J Dermatol Venereol Leprol; 2015; 81(4):356-62. PubMed ID: 26144850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug therapy in leprosy can prevent relapse--a retrospective study.
    Biswas S; Mondal KK
    Indian J Lepr; 2002; 74(4):313-8. PubMed ID: 12624979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of thickened nerve trunks and skin lesions of leprosy patients to MDT.
    Porichha D; Rao AK; Nehemaiah E; Mishra MC
    Indian J Lepr; 2011; 83(1):31-5. PubMed ID: 21638981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapses in multibacillary leprosy patients after multidrug therapy.
    Poojabylaiah M; Marne RB; Varikkodan R; Bala N; Dandakeri S; Martis J
    Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.
    Shetty VP; Khambati FA; Ghate SD; Capadia GD; Pai VV; Ganapati R
    Lepr Rev; 2010 Mar; 81(1):41-58. PubMed ID: 20496569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapses in paucibacillary leprosy after MDT--a clinical study.
    Grugni A; Nadkarni NJ; Kini MS; Mehta VR
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical assessment of paucibacillary leprosy under multidrug therapy-three years followup study.
    Revankar CR; Karjivkar VG; Gurav VJ; Ganapati R
    Indian J Lepr; 1989 Jul; 61(3):355-9. PubMed ID: 2768883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines.
    Maghanoy A; Mallari I; Balagon M; Saunderson P
    Lepr Rev; 2011 Mar; 82(1):65-9. PubMed ID: 21644473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.